The Drug Controller General of India on Sunday granted permission to the Serum Institute of India in Pune to conduct phase two and three human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca, PTI reported. Read the full story at Scroll.in
In rural India and other places where tuberculosis is rampant, A.I. that scans lung X-rays might eliminate the scourge. Read the full article in The New York Times.